Re: Long Term Follow-Up and Outcomes of Re-Treatment in an Expanded 50 Patient Single-Center Phase II Prospective Trial of Lutetium-177 (177Lu) PSMA-617 Theranostics in Metastatic Castrate-Resistant Prostate Cancer

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish (US)
    Number of pages1
    JournalThe Journal of urology
    Volume203
    Issue number5
    DOIs
    StatePublished - May 1 2020

    ASJC Scopus subject areas

    • Urology

    Cite this